Financial Performance Highlights (₹ in lakhs)

FY 2025-26 vs FY 2024-25:

  • Turnover: ₹1,123.33 (vs ₹1,245.96 in FY25) - 9.8% decrease
  • Profit Before Tax: ₹20.71 (vs ₹25.47 in FY25) - 18.7% decrease
  • Profit After Tax: ₹5.33 (vs ₹44.97 in FY25) - 88.2% decrease
  • Other Income: ₹2.10 (vs ₹2.11 in FY25)
  • Finance Costs: ₹0.91 (vs ₹1.49 in FY25)
  • Depreciation: ₹5.64 (vs ₹121.84 in FY25)

Key Financial Ratios

  • Operating Profit Margin: 2.49% (vs 2.33% in FY25)
  • Net Profit Margin: 0.44% (vs 3.61% in FY25)
  • Current Ratio: 0.79 (vs 0.69 in FY25)
  • Debt Service Coverage Ratio: 257 (vs 292.45 in FY25)

Capital Structure

  • Authorized Capital: ₹15,00,00,000 (1.5 crore shares of ₹10 each)
  • Paid-up Capital: ₹14,86,07,000 (1,48,60,700 shares of ₹10 each)
  • No change in share capital during the year

AGM Details

The 32nd Annual General Meeting will be held on:

  • Date: Wednesday, 30 September 2026
  • Time: 9:00 AM
  • Venue: Survey No.182, Yellampet Village, Medchal Mandal, Medchal District, Telangana-501401

Business to be Transacted

Ordinary Business:

1. Adoption of audited financial statements for FY 2025-26

2. Reappointment of Mr. A. Sai Balaji Krishna Teja (DIN: 07003946) as Non-Executive Director retiring by rotation

Special Business:

3. Continuation of Mrs. Padma Ghanakota (DIN: 07078176) as Non-Executive Director

4. Reappointment of Mr. Bhagat Reddy Dundumulla (DIN: 07087331) as Managing Director for 5 years from 7 September 2026

Board and Management Details

Board Composition (6 Directors):

  • Managing Director: Mr. Bhagat Reddy Dundumulla
  • Non-Executive Directors: Mrs. Padma Ghanakota, Mr. A. Sai Balaji Krishna Teja
  • Independent Directors: Mr. Rajesh Kakkera, Mr. M. Madhavarao, Mr. Addagarla Tarun

Key Managerial Personnel:

  • CFO: Mrs. S Vijayagowri Satyabhavani (appointed w.e.f. 24.02.2026)
  • CEO: Mr. A. Bala Gopal
  • Company Secretary: Mr. T. Abhilash

Corporate Actions

  • Dividend: No dividend recommended for FY 2025-26
  • Transfer to Reserves: No amount transferred to general reserves
  • ESOP: No employee stock option scheme exists

Regulatory and Compliance Matters

Secretarial Audit Qualifications (10 key issues):

1. Non-compliance with Regulation 47(1) of SEBI LODR - financial results not published in newspapers

2. Independent Directors' declarations of independence not furnished for audit verification

3. Board and committee meeting records not produced for audit

4. Failure to intimate BSE about convening of Board meetings for FY 2024-25

5. Statutory registers not maintained as prescribed under Companies Act

6. DIR-8 and MBP-1 disclosures not provided for audit

7. Independent Directors failed to register/renew with IICA databank

8. Annual performance evaluation of Board not conducted

9. Meeting dispatch acknowledgments not maintained

10. Attendance registers for meetings not maintained

Listing Status:

  • Company remains suspended on BSE due to "penal reasons"
  • Securities Appellate Tribunal had ordered restoration of listing on 17 April 2025 after company contested BSE's delisting order dated 28 November 2024

Operational Highlights

  • Business: Manufacturer of medical disposables and surgical products under "SAFTI" brand
  • Product Portfolio: IV sets, disposable syringes, needles, catheters, cannulas, Ayurvedic and nutraceutical products
  • Production Capacity: IV sets - 40 million units p.a., Syringes - 264 million units p.a., Needles - 135 million units p.a.
  • Factories: Two manufacturing units in Telangana (Medchal and Karimnagar districts)

Related Party Transactions

Outstanding Loans (₹ in lakhs):

  • From A. Balagopal: ₹574.01 (₹561.18 in FY25)
  • From G. Padma: ₹31.72 (₹30.35 in FY25)
  • From Sri Siri Constructions: ₹1,279.99 (₹1,297.64 in FY25)

Shareholding Pattern (as on 31 March 2026)

  • Promoters & Promoter Group: 70.12%
  • Public Institutions: 8.43%
  • Non-Institutions: 21.44%
  • Dematerialization Status: 76.20% shares in demat form (CDSL: 75.52%, NSDL: 0.68%), 23.80% in physical form

Other Significant Disclosures

  • Book Closure: 24 September 2026 to 30 September 2026 (both days inclusive)
  • E-voting Period: 27 September 2026 (9:00 AM) to 29 September 2026 (5:00 PM)
  • Cut-off Date: 23 September 2026 for e-voting eligibility
  • Scrutinizer: M/s Chakravarthy & Associates appointed for e-voting process
  • Pending Statutory Dues: ₹57.98 lakhs (TDS: ₹48.46L, Professional Tax: ₹7.20L, PF & ESI: ₹2.32L)
  • Contingent Liabilities: None reported
  • CSR: Not applicable as company doesn't meet threshold criteria